172883-97-5

Basic information

• Product Name: 3-pseudotropyl-4fluorobenzoate
• Synonyms: 3-pseudotropyl-4fluorobenzoate;4-Fluorotropacocaine;3-(p-Fluorobenzoyloxy)tropane;Pseudotropine 4-Fluorobenzoate;Benzoic acid,4-fluoro-, 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl ester, exo- (9CI);(3-exo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoate
• CAS NO: 172883-97-5
• Molecular Formula: C15H18FNO2
• Molecular Weight: 263.3073232
• Mol File: 172883-97-5.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 344.0±32.0 °C(Predicted)
• Appearance: /
• Density: 1.21±0.1 g/cm3(Predicted)
• PKA: 9.95±0.40(Predicted)
• CAS DataBase Reference: 3-pseudotropyl-4fluorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 3-pseudotropyl-4fluorobenzoate(172883-97-5)
• EPA Substance Registry System: 3-pseudotropyl-4fluorobenzoate(172883-97-5)

Safety Data

• Hazardous Substances Data: 172883-97-5(Hazardous Substances Data)

Usage

Uses

Anaesthetic effects

Upstream product

• 456-22-4 4-Fluorobenzoic acid 
• 120-29-6 3-tropanol 

Relevant articles and documents

TROPINOL ESTERS AND RELATED COMPOUNDS TO PROMOTE NORMAL PROCESSING OF APP

In various embodiments, compositions and methods are provided for treatment and/or prevention of amyloidogenic diseases. In certain embodiments, the methods entail administering an effective amount of a tropinol ester to a subject in need thereof for prophylactic or therapeutic effect. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In certain embodiments, methods of reducing the risk, lessening the severity, or delaying the progression or onset of a disease characterized by beta-amyloid deposits in the brain of a mammal are also provided. In certain embodiments, methods of directly or indirectly inhibiting the C-terminal cleavage of APP resulting in the formation of APP-C31 peptide and APPneo (APP664) in a mammal are provided.